Clinical value of percutaneous coronary intervention to patients with chronic heart failure of coronary heart disease
LI Xing-zhou
WU Long-mei
SHI Yu-jie
ZHANG Jian
Abstract：Objective To study the clinical value of percutaneous coronary intervention (PCI) to patients with chronic heart failure (CHF) of coronary heart disease (CHD).Methods The in-hospital patients (n=66, male 51 and female 15) with heart failure and complete data were chosen from July 2013 to Mar. 2014, and then divided, according to revascularization modes, into PCI group (n=35) and CABG group (n=31). The changes of LVEF, NYHA grades, 6-minute walk test (6MWT) and curative effect were compared in 2 groups before and after treatment. Results The differences in the percentages of patients with lesion of anterior descending branch, 2-vessel lesion or 3-vessel lesion had no statistical significance between 2 groups (allP>0.05). Compared with before, in PCI group LVEF [(39.8±5.2)%vs. (53.9±6.0)%] and NYHA [(3.1±0.7)vs. (1.2±0.4)] were ameliorated (allP<0.05), and 6MWT [(222.5±126.9) mvs. (514.2±71.1) m] increased (P<0.01) after treatment. Compared with before, in CABG group LVEF [(39.45±5.3)%vs. (54.4 ±5.6)%] increased, NYHA [(3.2±0.7)vs. (1.3±0.6)] were ameliorated (all P<0.05), and 6MWT [(215.4 ±125.3) mvs. (511.2±78.1) m] increased (P<0.01) after treatment.Conclusion PCI can improve heart function in patients with CHF of CHD, and its curative effect is the same as that of CABG, which is positive to patients' prognosis.
Keywords：Percutaneous coronary interventionCoronary heart diseaseHeart failureClinical value
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 255-257,261 )